Likelihood of malignancy did not differ between boys and girls.
Sonographic characteristics associated with malignant thyroid nodules in children included solitary nodules, larger nodule size, and solid parenchyma, taller-than-wide shape, among others, according to a study published in the journal Radiology.
Researchers from Brigham and Women’s Hospital and Boston Children’s Hospital in Massachusetts sought to determine the relationship between demographic and sonographic characteristics of thyroid nodules and malignancy in a pediatric population. The researchers obtained data from 314 patients, mean age 14.9 years, who underwent US-guided fine-needle aspiration biopsy for a total of 404 nodules. Eighty-two percent of the patients were female.
The results showed that 77 nodules (19.1 percent) were malignant, and 68 (88.3 percent) of these were papillary thyroid carcinoma. Sonographic characteristics associated with malignant nodules included:
• Larger size
• Solid parenchyma
• Taller-than-wide shape
• Presence of speckled calcifications
• Lack of a smooth margin
• Presence of abnormal lymph nodes
The researchers did not find that the likelihood of malignancy differed between boys and girls (27.8 percent versus 22.7 percent.) There was also no difference in likelihood between prepubertal and pubertal patients (18.8 percent versus 19.1 percent, respectively). The cancer rate in patients with a solitary nodule was higher than that in patients with multiple nodules (29.4 percent versus 14.2 percent, respectively).
Interobserver variability for assessment of sonographic characteristics ranged from moderate to very strong.
MRI or Ultrasound for Evaluating Pelvic Endometriosis?: Seven Takeaways from a New Literature Review
September 13th 2024While noting the strength of MRI for complete staging of disease and ultrasound’s ability to provide local disease characterization, the authors of a new literature review suggest the two modalities offer comparable results for diagnosing pelvic endometriosis.
The Reading Room: Racial and Ethnic Minorities, Cancer Screenings, and COVID-19
November 3rd 2020In this podcast episode, Dr. Shalom Kalnicki, from Montefiore and Albert Einstein College of Medicine, discusses the disparities minority patients face with cancer screenings and what can be done to increase access during the pandemic.
FDA Clears Controlled Contrast Delivery Method for Ultrasound Imaging of Fallopian Tubes
September 9th 2024Facilitating natural contrast delivery through an intrauterine catheter, FemChec can be utilized for ultrasound assessment of fallopian tubes and may provide diagnostic confirmation for an emerging non-surgical option for permanent birth control.
FDA Clears Emerging Cardiovascular Point-of-Care Ultrasound Platform
August 22nd 2024Combining four CAD modules for valvular pathologies with a variety of automated measurements, the AI-enabled AISAP Cardio ultrasound system reportedly facilitates up to a 90 percent accuracy rate in detecting common cardiac conditions.
Predicting DCIS Upgrade to Invasive Breast Cancer: Can Contrast-Enhanced Ultrasound Have an Impact?
August 21st 2024Adding two key findings from contrast-enhanced ultrasound to a predictive model of mammography, conventional ultrasound and clinicopathological findings led to a 86.1 percent AUROC for predicting the upgrading of ductal carcinoma in situ to invasive breast cancer, according to new research.